PL2575865T3 - Kompozycja farmaceutyczna obejmująca AVE0010 i insulinę glargine - Google Patents
Kompozycja farmaceutyczna obejmująca AVE0010 i insulinę glargineInfo
- Publication number
- PL2575865T3 PL2575865T3 PL11723919T PL11723919T PL2575865T3 PL 2575865 T3 PL2575865 T3 PL 2575865T3 PL 11723919 T PL11723919 T PL 11723919T PL 11723919 T PL11723919 T PL 11723919T PL 2575865 T3 PL2575865 T3 PL 2575865T3
- Authority
- PL
- Poland
- Prior art keywords
- ave0010
- pharmaceutical composition
- insulin glargine
- glargine
- insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10164368A EP2389945A1 (en) | 2010-05-28 | 2010-05-28 | Pharmaceutical composition comprising AVE0010 and insulin glargine |
PCT/EP2011/058764 WO2011147980A1 (en) | 2010-05-28 | 2011-05-27 | Pharmaceutical composition comprising ave0010 and insulin glargine |
EP11723919.4A EP2575865B1 (en) | 2010-05-28 | 2011-05-27 | Pharmaceutical Composition Comprising AVE0010 and Insulin Glargine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2575865T3 true PL2575865T3 (pl) | 2015-06-30 |
Family
ID=42773054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11723919T PL2575865T3 (pl) | 2010-05-28 | 2011-05-27 | Kompozycja farmaceutyczna obejmująca AVE0010 i insulinę glargine |
Country Status (9)
Country | Link |
---|---|
US (1) | US20130079279A1 (pl) |
EP (4) | EP2389945A1 (pl) |
AR (1) | AR081254A1 (pl) |
DK (1) | DK2575865T3 (pl) |
ES (1) | ES2532994T3 (pl) |
HU (1) | HUE024486T2 (pl) |
PL (1) | PL2575865T3 (pl) |
TW (1) | TW201201832A (pl) |
WO (1) | WO2011147980A1 (pl) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE519780T1 (de) | 2005-12-28 | 2011-08-15 | Novo Nordisk As | Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen |
HUE037449T2 (hu) | 2008-10-17 | 2018-08-28 | Sanofi Aventis Deutschland | Egy inzulin és egy GLP-1 agonista kombinációja |
KR20110085985A (ko) | 2008-10-30 | 2011-07-27 | 노보 노르디스크 에이/에스 | 하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료 |
PE20121316A1 (es) | 2009-11-13 | 2012-10-05 | Sanofi Aventis Deutschland | Composicion farmaceutica que comprende un agonista de glp-1 y metionina |
RU2537239C2 (ru) | 2009-11-13 | 2014-12-27 | Санофи-Авентис Дойчланд Гмбх | Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин |
AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
PT2611458T (pt) | 2010-08-30 | 2016-12-16 | Sanofi Aventis Deutschland | Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2 |
DK2632478T3 (da) | 2010-10-27 | 2019-10-07 | Novo Nordisk As | Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
DK2741765T3 (en) | 2011-08-10 | 2016-06-13 | Adocia | Injectable solution of at least one type of basal insulin |
PT2750699E (pt) | 2011-08-29 | 2015-11-03 | Sanofi Aventis Deutschland | Acelerómetro pendular |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
BR112014016889A8 (pt) | 2012-01-09 | 2017-07-04 | Adocia | composição sob a forma de uma solução aquosa injetável, sujo ph está compreendido entre 6,0 e 8,0 e, formulação de dose unitária com ph compreendido entre 7 e 7,8 |
US20150314003A2 (en) | 2012-08-09 | 2015-11-05 | Adocia | Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer |
FR3001896B1 (fr) | 2013-02-12 | 2015-07-03 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le point isolectrique est compris entre 5,8 et 8,5 et un polymere anionique hydrophobise |
FR3001895B1 (fr) | 2013-02-12 | 2015-07-03 | Adocia | Solution injectable a ph7 comprenant au moins une insuline basale dont le point isoelectrique est compris en 5,8 et 8,5 et un compose anionique porteur de charges carboxylates et de radicaux hydrophobes |
TWI780236B (zh) | 2013-02-04 | 2022-10-11 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
HUE042381T2 (hu) * | 2013-04-03 | 2019-06-28 | Sanofi Sa | Cukorbetegség kezelése hosszan ható inzulinkészítményekkel |
EP2991672A1 (en) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
SG10201710347PA (en) * | 2013-06-17 | 2018-01-30 | Sanofi Aventis Deutschland | Insulin glargine/lixisenatide fixed ratio formulation |
AU2015205620A1 (en) | 2014-01-09 | 2016-07-14 | Sanofi | Stabilized pharmaceutical formulations of insulin aspart |
WO2015104314A1 (en) | 2014-01-09 | 2015-07-16 | Sanofi | Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives |
RU2016132386A (ru) | 2014-01-09 | 2018-02-14 | Санофи | Стабилизированные фармацевтические составы без глицерина на основе инсулиновых аналогов и/или инсулиновых производных |
WO2015170286A2 (en) * | 2014-05-08 | 2015-11-12 | Biolingus Ip Llc | Modulation of blood glucose levels |
CA2970200A1 (en) * | 2014-12-12 | 2016-06-16 | Sanofi-Aventis Deutschland Gmbh | Insulin glargine/lixisenatide fixed ratio formulation |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
EA039114B1 (ru) * | 2015-11-10 | 2021-12-06 | Санофи-Авентис Дойчланд Гмбх | Применение композиции с постоянным соотношением инсулин гларгин/ликсисенатид для лечения сахарного диабета 2 типа |
WO2018055539A1 (en) * | 2016-09-22 | 2018-03-29 | Wockhardt Limited | Pharmaceutical composition containing buffered insulin glargine and glp-1 analogue |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
CN117558435B (zh) * | 2024-01-11 | 2024-03-19 | 四川省医学科学院·四川省人民医院 | 一种基于bcm设备的远程透析指导系统 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1076066A1 (en) | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
JP5693817B2 (ja) * | 2005-08-19 | 2015-04-01 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | 糖尿病の治療法および体重の減少法 |
DE102008053048A1 (de) * | 2008-10-24 | 2010-04-29 | Sanofi-Aventis Deutschland Gmbh | Kombination von einem Insulin und einem GLP-1-Agonisten |
-
2010
- 2010-05-28 EP EP10164368A patent/EP2389945A1/en not_active Ceased
-
2011
- 2011-05-27 HU HUE11723919A patent/HUE024486T2/en unknown
- 2011-05-27 AR ARP110101825A patent/AR081254A1/es unknown
- 2011-05-27 EP EP11723919.4A patent/EP2575865B1/en not_active Not-in-force
- 2011-05-27 TW TW100118675A patent/TW201201832A/zh unknown
- 2011-05-27 ES ES11723919.4T patent/ES2532994T3/es active Active
- 2011-05-27 EP EP14197154.9A patent/EP2898895A1/en not_active Ceased
- 2011-05-27 PL PL11723919T patent/PL2575865T3/pl unknown
- 2011-05-27 EP EP17202727.8A patent/EP3300741A1/en not_active Withdrawn
- 2011-05-27 WO PCT/EP2011/058764 patent/WO2011147980A1/en active Application Filing
- 2011-05-27 DK DK11723919.4T patent/DK2575865T3/en active
- 2011-05-27 US US13/700,631 patent/US20130079279A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2898895A1 (en) | 2015-07-29 |
AR081254A1 (es) | 2012-07-18 |
EP2389945A1 (en) | 2011-11-30 |
WO2011147980A1 (en) | 2011-12-01 |
ES2532994T3 (es) | 2015-04-06 |
US20130079279A1 (en) | 2013-03-28 |
TW201201832A (en) | 2012-01-16 |
HUE024486T2 (en) | 2016-01-28 |
DK2575865T3 (en) | 2015-03-23 |
EP2575865B1 (en) | 2014-12-17 |
EP2575865A1 (en) | 2013-04-10 |
EP3300741A1 (en) | 2018-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2575865T3 (pl) | Kompozycja farmaceutyczna obejmująca AVE0010 i insulinę glargine | |
IL253870B (en) | Certain amino-pyrimidines and pharmaceutical preparations containing them | |
HK1205690A1 (en) | Pharmaceutical composition and administration thereof | |
EP2583703A4 (en) | SELF-DAMAGING INSULIN SPRING WITH REPLACEABLE NEEDLE | |
HK1182496A1 (en) | Insulin delivery device | |
HK1248593A1 (zh) | 長效胰島素製劑 | |
EP2598527A4 (en) | RECOMBINANT EXPRESSED INSULIN POLYPEPTIDES AND APPLICATIONS THEREOF | |
ZA201301419B (en) | Pharmaceutical composition and administrations thereof | |
GB201217611D0 (en) | Immediate/delayed drug delivery | |
EP2563338A4 (en) | HIGH SHEAR APPLICATION USED FOR DRUG DELIVERY | |
SG11201400293UA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
PL2523666T3 (pl) | Kompozycja farmaceutyczna zawierająca 3-beta-hydroksy-5-alfa-pregnan-20-on o ulepszonych właściwościach przechowywania i rozpuszczalności | |
EP2718283A4 (en) | INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | |
ZA201409508B (en) | Pharmaceutical composition comprising fimasartan and hydrochlorothiazide | |
EP2653181A4 (en) | MOUTHPIECE TIP OF DRUG POWDER AND USE THEREOF | |
EP2586324A4 (en) | TRANSDERMAL ADMINISTRATION BRACELET | |
IL223707A0 (en) | N-hydroxyformamide derivative and medicament containing same | |
SG10201601324VA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
IL221501A (en) | Medicinal product containing miramistine | |
HK1175456A1 (en) | Anti-leishmania compound and anti-leishmania drug | |
HRP20150125T1 (hr) | Farmaceutski oblik koji sadrži aspirin i bisoprolol | |
GB201012660D0 (en) | Inhaler and formulation | |
EP2657236A4 (en) | NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE | |
GB201112578D0 (en) | Pharmaceutical preparation and use | |
GB201002451D0 (en) | Pharmaceutical comopitions and devices |